MedMira Holding AG develops and commercializes rapid diagnostic tests and technology based on its patented Rapid Vertical Flow (RVF) platform, including single-use tests such as Reveal G4 for HIV and Multiplo multiplex assays for HIV, hepatitis and syphilis. The product range also includes Miriad research tools and RVF toolkits for diagnostic development and applications such as tissue-banking.
AI-generated
Offering
Products & services
Industry:Holding Companies
✓ Offered7
Rapid diagnostic tests
Rapid diagnostic tests for HIV-1/2, syphilis (TP), HCV and combinations; for screening and diagnostic applications in point-of-care, laboratory and research settings.
RVF Technology™
Rapid Vertical Flow technology for immediate results, antigen- and antibody-based tests, single and multiplex formats, and applications from the clinic to the field.
Miriad® RVF-Toolkit
Toolkit for developing rapid assays and prototypes; materials and support for antibody or antigen detection based on Rapid Vertical Flow Technology™.
OEM and private-label development
OEM and private-label solutions for rapid diagnostic solutions; adaptation of targets, panel composition, format, design and branding up to market launch.
Assay development and conversion
Development of new assays from concept and prototype through to validation; conversion of existing test platforms to Rapid Vertical Flow Technology™ with design control support.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.